advanced anti-wrinkle therapy cicatricure

Generic: avobenxone 3%, octinoxate 7.5%, octisalate 5%, octocrylene 2.7%, oxybenzone 4%

Labeler: genomma lab
NDC Directory HUMAN OTC DRUG OTC MONOGRAPH NOT FINAL Inactive Finished

Drug Facts

Product Profile

Brand Name advanced anti-wrinkle therapy cicatricure
Generic Name avobenxone 3%, octinoxate 7.5%, octisalate 5%, octocrylene 2.7%, oxybenzone 4%
Labeler genomma lab
Dosage Form CREAM
Routes
TOPICAL
Active Ingredients

avobenzone 3 g/100g, octinoxate 7.5 g/100g, octisalate 5 g/100g, octocrylene 2.7 g/100g, oxybenzone 4 g/100g

Manufacturer
Genomma Lab

Identifiers & Regulatory

Product NDC 50066-021
Product ID 50066-021_8153c706-d1be-6c42-e053-2991aa0afda4
Product Type HUMAN OTC DRUG
Marketing Category OTC MONOGRAPH NOT FINAL
Application Number part352
Listing Expiration 2026-12-31
Marketing Start 2019-01-21

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 50066021
Hyphenated Format 50066-021

Supplemental Identifiers

UNII
G63QQF2NOX 4Y5P7MUD51 4X49Y0596W 5A68WGF6WM 95OOS7VE0Y

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name advanced anti-wrinkle therapy cicatricure (source: ndc)
Generic Name avobenxone 3%, octinoxate 7.5%, octisalate 5%, octocrylene 2.7%, oxybenzone 4% (source: ndc)
Application Number part352 (source: ndc)
Routes
TOPICAL
source: ndc

Resolved Composition

Strengths
  • 3 g/100g
  • 7.5 g/100g
  • 5 g/100g
  • 2.7 g/100g
  • 4 g/100g
source: ndc
Packaging
  • 1 TUBE in 1 CARTON (50066-021-01) / 42 g in 1 TUBE
source: ndc

Packages (1)

50066-021-01 1 TUBE in 1 CARTON (50066-021-01) / 42 g in 1 TUBE

Ingredients (5)

avobenzone (3 g/100g) octinoxate (7.5 g/100g) octisalate (5 g/100g) octocrylene (2.7 g/100g) oxybenzone (4 g/100g)

Linked Drug Pages (1)

Advanced Anti-Wrinkle Therapy Cicatricure ndc-match (0.9)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["TOPICAL"], "spl_id": "8153c706-d1be-6c42-e053-2991aa0afda4", "openfda": {"unii": ["G63QQF2NOX", "4Y5P7MUD51", "4X49Y0596W", "5A68WGF6WM", "95OOS7VE0Y"], "spl_set_id": ["8153c706-d1bd-6c42-e053-2991aa0afda4"], "manufacturer_name": ["Genomma Lab"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "1 TUBE in 1 CARTON (50066-021-01)  / 42 g in 1 TUBE", "package_ndc": "50066-021-01", "marketing_start_date": "20190121"}], "brand_name": "Advanced Anti-Wrinkle Therapy Cicatricure", "product_id": "50066-021_8153c706-d1be-6c42-e053-2991aa0afda4", "dosage_form": "CREAM", "product_ndc": "50066-021", "generic_name": "Avobenxone 3%, Octinoxate 7.5%, Octisalate 5%, Octocrylene 2.7%, Oxybenzone 4%", "labeler_name": "Genomma Lab", "product_type": "HUMAN OTC DRUG", "brand_name_base": "Advanced Anti-Wrinkle Therapy", "brand_name_suffix": "Cicatricure", "active_ingredients": [{"name": "AVOBENZONE", "strength": "3 g/100g"}, {"name": "OCTINOXATE", "strength": "7.5 g/100g"}, {"name": "OCTISALATE", "strength": "5 g/100g"}, {"name": "OCTOCRYLENE", "strength": "2.7 g/100g"}, {"name": "OXYBENZONE", "strength": "4 g/100g"}], "application_number": "part352", "marketing_category": "OTC MONOGRAPH NOT FINAL", "marketing_start_date": "20190121", "listing_expiration_date": "20261231"}